Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PROC | US
-0.01
-0.55%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
19/09/2024
1.80
1.88
1.88
1.69
Procaps Group S.A. develops produces and markets pharmaceutical solutions worldwide. The company formulates manufactures and markets branded prescription drugs in various therapeutic areas including feminine care products pain relief skin care digestive health growth and development cardiology vision care central nervous system and respiratory. It also provides drugs for hospital use such as antibiotic blood clot personal protective equipment immunosuppressant oncology and analgesics products. In addition the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas including gastrointestinal skin care cough and cold analgesics urological vitamins minerals and supplements in the categories of antibiotics anti-infective anti-parasitic cardiovascular feminine care cutaneous antimycotic pain killers gastro intestinal hormonals metabolic endocrine nervous system ophthalmic osteoarticular respiratory diet supplements and vitamins and minerals. Further it provides blood glucose meters telemonitoring products oral anti-diabetics products cosmeceuticals insulin delivery systems and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg Luxembourg.
View LessLow Market Beta (-0.4 to 0.8)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
65.0%1 month
49.9%3 months
49.9%6 months
54.1%3.63
81.30
5.30
-
-
3.83
1.14
-
57.06M
203.08M
203.08M
-
11.13
-63.70
7.30
37.37
1.04
0.03
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.33
Range1M
0.50
Range3M
1.19
Rel. volume
6.24
Price X volume
51.32K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.84 | 176.87M | 4.80% | n/a | -113.78% |
LFCR | LFCR | Drug Manufacturers-Specialty & Generic | 5.62 | 173.65M | 8.08% | 20.72 | 241.85% |
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 2.25 | 157.36M | 2.27% | n/a | 1.07% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.13 | 129.73M | 1.96% | n/a | 1.10% |
Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 1.35 | 128.70M | 3.85% | n/a | 30.76% |
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.52 | 125.25M | 4.11% | n/a | 8.14% |
OptiNose Inc | OPTN | Drug Manufacturers-Specialty & Generic | 0.7956 | 119.96M | -6.40% | n/a | -294.40% |
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.8012 | 117.28M | 4.05% | n/a | 36.36% |
Relmada Therapeutics Inc | RLMD | Drug Manufacturers-Specialty & Generic | 3.5 | 105.61M | 0.29% | n/a | 0.00% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.7391 | 92.15M | 0.35% | n/a | -148.05% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Unifi Inc | UFI | Textile Manufacturing | 7.59 | 138.98M | 6.60% | n/a | 52.56% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 37.9 | 107.64M | -1.76% | 5.90 | 15.58% |
Culp Inc | CULP | Textile Manufacturing | 6.35 | 79.31M | 5.31% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 5.78 | 62.58M | -6.47% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.04 | 18.78M | 13.06% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 12.43M | -7.27% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.737 | 11.34M | 3.80% | n/a | 422.08% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6475 | 6.16M | -2.76% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.315 | 4.97M | -1.56% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.42 | 3.63M | 1.43% | n/a | 9.62% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 3.83 | 16.67 | Cheaper |
Ent. to Revenue | 1.14 | 309.37 | Cheaper |
PE Ratio | 3.63 | 29.14 | Cheaper |
Price to Book | 5.30 | 12.81 | Cheaper |
Dividend Yield | - | 2.80 | - |
Std. Deviation (3M) | 49.89 | 75.12 | Lower Risk |
Debt to Equity | - | -0.93 | - |
Debt to Assets | - | 0.45 | - |
Market Cap | 203.08M | 5.22B | Emerging |